
LINK . SPRINGER . COM {
}
Title:
iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy | Trials
Description:
Background HIV therapeutic vaccination aims to improve the immune responses against HIV in order to control viral replication without the need for combined antiretroviral therapy (cART). iHIVARNA-01 is a novel vaccine combining mRNA delivery and T-cell immunogen (HTI) based on conserved targets of effective antiviral T-cell responses. In addition, it holds adequate stimuli required for activating antigen presenting cells (APC)s and co-activating specific T-cells (TriMix), including human CD40L, constitutively active TLR4 (caTLR4) and CD70. We propose that in-vivo targeting of dendritic cells (DCs) by direct administration of a HIV mRNA encoding these immune modulating proteins might be an attractive alternative to target DCs in vitro. Methods/design This is a phase-IIa, randomized, double-blinded, placebo-controlled, multicenter study in chronically HIV-1 infected patients under stable cART. One of the three study arms is randomly allocated to subjects. Three vaccinations with either HIVACAT T-cell immunogen (HTI)-TriMix (iHIVARNA-01), TriMix or water for injection (WFI) (weeks 0, 2 and 4) are administered by intranodal injection in the inguinal region. Two weeks after the last immunization (week 6) cART is stopped for 12âweeks. The two primary endpoints are: (1) safety and tolerability of intranodal iHIVARNA-01 vaccination compared with TriMix or WFI and (2) induced immunogenicity, i.e., increase in the frequency of HIV-specific T-cell responses between baseline, week 6 and 12âweeks after treatment interruption in iHIVARNA-01-treated patients as compared to the control groups, immunized with TriMix-mRNA or WFI measured by an IFNÎł ELISPOT assay. Secondary endpoints include the evaluation of time to viral rebound, plasma viral load (pVL) at w18, the proportion of patients with control of viral load, induction of T-cell responses to new HIV epitopes, polyfunctionality of HIV-specific T-cells, CD8+ T-cell in-vitro HIV suppressive capacity, the effect on viral reservoir (measured by proviral DNA and cell-associated RNA), assessment of viral immune escape by mutation and mRNA expression profiles of host immune genes. Discussion This trial aims to direct target DC in situ with mRNA encoding HTI and TriMix for co-stimulation. Intranodal injection circumvents laborious DC isolation and handling in the laboratory. The trial extends on the safety results of a phase-I dose-escalating trial. This candidate vaccine could complement or even replace cART for chronic HIV infection and could be applicable to improve the care and cost of HIV infection. Trial registration EudraCT 2016-002724-83 (22 September 2016); ClinicalTrials.gov, ID: NCT02888756. Registered on 23 August 2016.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {đ}
- Science
- Education
- Health & Fitness
Content Management System {đ}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {đ}
What is the average monthly size of link.springer.com audience?
đ Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {đ¸}
We're unsure if the website is profiting.
Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.
Keywords {đ}
hiv, study, article, patients, viral, cart, ihivarna, tcell, week, google, scholar, vaccination, trial, treatment, immune, responses, trimix, interruption, control, mrna, weeks, virus, patient, cas, safety, therapy, van, vaccine, hti, investigator, hivinfected, load, infection, prior, data, including, full, injection, immunotherapy, days, consent, phase, cells, active, dcs, clinical, barcelona, adverse, ati, period,
Topics {âď¸}
int/hiv/pub/progressreports/2016-progress-report/en/ prominent lymph node cross-presenting dendritic cells immunogen-specific t-cell response hiv-specific t-cell responses hti-specific t-cell responses broad t-cell specificities broad variant cross-reactivity patient-derived cd8+ t-cells induce t-cell responses hivacat t-cell immunogen int/hiv/data/en/ potent cancer immunotherapy mrna expression profiles dc-based vaccine offers org/guide/hiv-classification-cdc nadir cd4+ââĽâ350 cells/Îźl enhance t-cell activation t-cell elispot essay t-cell stimulatory capacity ad26/mva therapeutic vaccination activating specific t-cells hiv-specific t-cells beatriz mothe chronic hiv-infected patients autologous b-cells expressing nonsteroidal anti-inflammatory drugs positive-sense ribonucleic acid vaccine-induced immune response siv-infected rhesus monkeys highly hiv-exposed individuals coincident ad26/mva vaccination lysing hiv-infected cells vitals/lymph nodes lay-man interpretable results early-treated hiv-1 infection t-cell responses cd4+ cell counts vaccine-induced immune pressure article download pdf double-stranded deoxyribonucleic acid conduct sieve-effect analyses phase-iia clinical trial hti vaccines combined chronically hiv-infected patients t-cell immunogen hiv-1 infection induces called âblipsâââ¤â500 copies/ml author information authors high functional avidity
Schema {đşď¸}
WebPage:
mainEntity:
headline:iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
description:HIV therapeutic vaccination aims to improve the immune responses against HIV in order to control viral replication without the need for combined antiretroviral therapy (cART). iHIVARNA-01 is a novel vaccine combining mRNA delivery and T-cell immunogen (HTI) based on conserved targets of effective antiviral T-cell responses. In addition, it holds adequate stimuli required for activating antigen presenting cells (APC)s and co-activating specific T-cells (TriMix), including human CD40L, constitutively active TLR4 (caTLR4) and CD70. We propose that in-vivo targeting of dendritic cells (DCs) by direct administration of a HIV mRNA encoding these immune modulating proteins might be an attractive alternative to target DCs in vitro. This is a phase-IIa, randomized, double-blinded, placebo-controlled, multicenter study in chronically HIV-1 infected patients under stable cART. One of the three study arms is randomly allocated to subjects. Three vaccinations with either HIVACAT T-cell immunogen (HTI)-TriMix (iHIVARNA-01), TriMix or water for injection (WFI) (weeks 0, 2 and 4) are administered by intranodal injection in the inguinal region. Two weeks after the last immunization (week 6) cART is stopped for 12âweeks. The two primary endpoints are: (1) safety and tolerability of intranodal iHIVARNA-01 vaccination compared with TriMix or WFI and (2) induced immunogenicity, i.e., increase in the frequency of HIV-specific T-cell responses between baseline, week 6 and 12âweeks after treatment interruption in iHIVARNA-01-treated patients as compared to the control groups, immunized with TriMix-mRNA or WFI measured by an IFNÎł ELISPOT assay. Secondary endpoints include the evaluation of time to viral rebound, plasma viral load (pVL) at w18, the proportion of patients with control of viral load, induction of T-cell responses to new HIV epitopes, polyfunctionality of HIV-specific T-cells, CD8+ T-cell in-vitro HIV suppressive capacity, the effect on viral reservoir (measured by proviral DNA and cell-associated RNA), assessment of viral immune escape by mutation and mRNA expression profiles of host immune genes. This trial aims to direct target DC in situ with mRNA encoding HTI and TriMix for co-stimulation. Intranodal injection circumvents laborious DC isolation and handling in the laboratory. The trial extends on the safety results of a phase-I dose-escalating trial. This candidate vaccine could complement or even replace cART for chronic HIV infection and could be applicable to improve the care and cost of HIV infection. EudraCT 2016-002724-83 (22 September 2016); ClinicalTrials.gov, ID: NCT02888756. Registered on 23 August 2016.
datePublished:2019-06-17T00:00:00Z
dateModified:2019-12-13T00:00:00Z
pageStart:1
pageEnd:10
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13063-019-3409-1
keywords:
HIV-1
Therapeutic vaccine
Functional cure
Immunotherapy
Reservoir
Lymph node
TriMix
Antigen-presenting cell
Medicine/Public Health
general
Biomedicine
Statistics for Life Sciences
Medicine
Health Sciences
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-019-3409-1/MediaObjects/13063_2019_3409_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-019-3409-1/MediaObjects/13063_2019_3409_Fig2_HTML.png
isPartOf:
name:Trials
issn:
1745-6215
volumeNumber:20
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Wesley de Jong
url:http://orcid.org/0000-0001-9674-2647
affiliation:
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Joeri Aerts
affiliation:
name:Vrije Universiteit Brussel
address:
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
type:PostalAddress
type:Organization
type:Person
name:Sabine Allard
affiliation:
name:Universitair Ziekenhuis Brussel
address:
name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
type:PostalAddress
type:Organization
type:Person
name:Christian Brander
affiliation:
name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
address:
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
type:Organization
name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
address:
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
type:PostalAddress
type:Organization
name:AELIX Therapeutics, Parc CientĂfic de Barcelona
address:
name:AELIX Therapeutics, Parc CientĂfic de Barcelona, Barcelona, Spain
type:PostalAddress
type:Organization
name:University of Vic â Central University of Catalonia (UVic-UCC)
address:
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
type:PostalAddress
type:Organization
type:Person
name:Jozefien Buyze
affiliation:
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:Eric Florence
affiliation:
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:Eric van Gorp
affiliation:
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Guido Vanham
affiliation:
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:Lorna Leal
affiliation:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
type:Organization
name:Hospital ClĂnic
address:
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
type:PostalAddress
type:Organization
type:Person
name:Beatriz Mothe
affiliation:
name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
address:
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
type:Organization
name:University of Vic â Central University of Catalonia (UVic-UCC)
address:
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
type:PostalAddress
type:Organization
type:Person
name:Kris Thielemans
affiliation:
name:Vrije Universiteit Brussel
address:
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
type:PostalAddress
type:Organization
type:Person
name:Montse Plana
affiliation:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
type:Organization
type:Person
name:FĂŠlipe Garcia
affiliation:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
type:Organization
name:Hospital ClĂnic
address:
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Rob Gruters
affiliation:
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
description:HIV therapeutic vaccination aims to improve the immune responses against HIV in order to control viral replication without the need for combined antiretroviral therapy (cART). iHIVARNA-01 is a novel vaccine combining mRNA delivery and T-cell immunogen (HTI) based on conserved targets of effective antiviral T-cell responses. In addition, it holds adequate stimuli required for activating antigen presenting cells (APC)s and co-activating specific T-cells (TriMix), including human CD40L, constitutively active TLR4 (caTLR4) and CD70. We propose that in-vivo targeting of dendritic cells (DCs) by direct administration of a HIV mRNA encoding these immune modulating proteins might be an attractive alternative to target DCs in vitro. This is a phase-IIa, randomized, double-blinded, placebo-controlled, multicenter study in chronically HIV-1 infected patients under stable cART. One of the three study arms is randomly allocated to subjects. Three vaccinations with either HIVACAT T-cell immunogen (HTI)-TriMix (iHIVARNA-01), TriMix or water for injection (WFI) (weeks 0, 2 and 4) are administered by intranodal injection in the inguinal region. Two weeks after the last immunization (week 6) cART is stopped for 12âweeks. The two primary endpoints are: (1) safety and tolerability of intranodal iHIVARNA-01 vaccination compared with TriMix or WFI and (2) induced immunogenicity, i.e., increase in the frequency of HIV-specific T-cell responses between baseline, week 6 and 12âweeks after treatment interruption in iHIVARNA-01-treated patients as compared to the control groups, immunized with TriMix-mRNA or WFI measured by an IFNÎł ELISPOT assay. Secondary endpoints include the evaluation of time to viral rebound, plasma viral load (pVL) at w18, the proportion of patients with control of viral load, induction of T-cell responses to new HIV epitopes, polyfunctionality of HIV-specific T-cells, CD8+ T-cell in-vitro HIV suppressive capacity, the effect on viral reservoir (measured by proviral DNA and cell-associated RNA), assessment of viral immune escape by mutation and mRNA expression profiles of host immune genes. This trial aims to direct target DC in situ with mRNA encoding HTI and TriMix for co-stimulation. Intranodal injection circumvents laborious DC isolation and handling in the laboratory. The trial extends on the safety results of a phase-I dose-escalating trial. This candidate vaccine could complement or even replace cART for chronic HIV infection and could be applicable to improve the care and cost of HIV infection. EudraCT 2016-002724-83 (22 September 2016); ClinicalTrials.gov, ID: NCT02888756. Registered on 23 August 2016.
datePublished:2019-06-17T00:00:00Z
dateModified:2019-12-13T00:00:00Z
pageStart:1
pageEnd:10
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s13063-019-3409-1
keywords:
HIV-1
Therapeutic vaccine
Functional cure
Immunotherapy
Reservoir
Lymph node
TriMix
Antigen-presenting cell
Medicine/Public Health
general
Biomedicine
Statistics for Life Sciences
Medicine
Health Sciences
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-019-3409-1/MediaObjects/13063_2019_3409_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13063-019-3409-1/MediaObjects/13063_2019_3409_Fig2_HTML.png
isPartOf:
name:Trials
issn:
1745-6215
volumeNumber:20
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Wesley de Jong
url:http://orcid.org/0000-0001-9674-2647
affiliation:
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Joeri Aerts
affiliation:
name:Vrije Universiteit Brussel
address:
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
type:PostalAddress
type:Organization
type:Person
name:Sabine Allard
affiliation:
name:Universitair Ziekenhuis Brussel
address:
name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
type:PostalAddress
type:Organization
type:Person
name:Christian Brander
affiliation:
name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
address:
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
type:Organization
name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
address:
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
type:PostalAddress
type:Organization
name:AELIX Therapeutics, Parc CientĂfic de Barcelona
address:
name:AELIX Therapeutics, Parc CientĂfic de Barcelona, Barcelona, Spain
type:PostalAddress
type:Organization
name:University of Vic â Central University of Catalonia (UVic-UCC)
address:
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
type:PostalAddress
type:Organization
type:Person
name:Jozefien Buyze
affiliation:
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:Eric Florence
affiliation:
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:Eric van Gorp
affiliation:
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
type:Person
name:Guido Vanham
affiliation:
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
type:Person
name:Lorna Leal
affiliation:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
type:Organization
name:Hospital ClĂnic
address:
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
type:PostalAddress
type:Organization
type:Person
name:Beatriz Mothe
affiliation:
name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
address:
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
type:Organization
name:University of Vic â Central University of Catalonia (UVic-UCC)
address:
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
type:PostalAddress
type:Organization
type:Person
name:Kris Thielemans
affiliation:
name:Vrije Universiteit Brussel
address:
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
type:PostalAddress
type:Organization
type:Person
name:Montse Plana
affiliation:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
type:Organization
type:Person
name:FĂŠlipe Garcia
affiliation:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
type:Organization
name:Hospital ClĂnic
address:
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Rob Gruters
affiliation:
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Trials
issn:
1745-6215
volumeNumber:20
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
name:Vrije Universiteit Brussel
address:
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
type:PostalAddress
name:Universitair Ziekenhuis Brussel
address:
name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
type:PostalAddress
name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
address:
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
address:
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
type:PostalAddress
name:AELIX Therapeutics, Parc CientĂfic de Barcelona
address:
name:AELIX Therapeutics, Parc CientĂfic de Barcelona, Barcelona, Spain
type:PostalAddress
name:University of Vic â Central University of Catalonia (UVic-UCC)
address:
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
type:PostalAddress
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
name:Hospital ClĂnic
address:
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
type:PostalAddress
name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
address:
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
name:University of Vic â Central University of Catalonia (UVic-UCC)
address:
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
type:PostalAddress
name:Vrije Universiteit Brussel
address:
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
type:PostalAddress
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
name:Hospital ClĂnic
address:
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
type:PostalAddress
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Wesley de Jong
url:http://orcid.org/0000-0001-9674-2647
affiliation:
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
name:Joeri Aerts
affiliation:
name:Vrije Universiteit Brussel
address:
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
type:PostalAddress
type:Organization
name:Sabine Allard
affiliation:
name:Universitair Ziekenhuis Brussel
address:
name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
type:PostalAddress
type:Organization
name:Christian Brander
affiliation:
name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
address:
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
type:Organization
name:Institució Catalana de Recerca i Estudis Avançats (ICREA)
address:
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
type:PostalAddress
type:Organization
name:AELIX Therapeutics, Parc CientĂfic de Barcelona
address:
name:AELIX Therapeutics, Parc CientĂfic de Barcelona, Barcelona, Spain
type:PostalAddress
type:Organization
name:University of Vic â Central University of Catalonia (UVic-UCC)
address:
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
type:PostalAddress
type:Organization
name:Jozefien Buyze
affiliation:
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
name:Eric Florence
affiliation:
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
name:Eric van Gorp
affiliation:
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
name:Guido Vanham
affiliation:
name:Institute of Tropical Medicine and
address:
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
type:PostalAddress
type:Organization
name:University of Antwerp
address:
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
type:PostalAddress
type:Organization
name:Lorna Leal
affiliation:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
type:Organization
name:Hospital ClĂnic
address:
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
type:PostalAddress
type:Organization
name:Beatriz Mothe
affiliation:
name:IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol
address:
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
type:PostalAddress
type:Organization
name:University of Vic â Central University of Catalonia (UVic-UCC)
address:
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
type:PostalAddress
type:Organization
name:Kris Thielemans
affiliation:
name:Vrije Universiteit Brussel
address:
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
type:PostalAddress
type:Organization
name:Montse Plana
affiliation:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
type:Organization
name:FĂŠlipe Garcia
affiliation:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
address:
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
type:PostalAddress
type:Organization
name:Hospital ClĂnic
address:
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
type:PostalAddress
type:Organization
email:[email protected]
name:Rob Gruters
affiliation:
name:Erasmus MC
address:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
name:Department of Internal Medicine and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
name:Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
name:AELIX Therapeutics, Parc CientĂfic de Barcelona, Barcelona, Spain
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
name:Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine and, Antwerp, Belgium
name:Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
name:Infectious Diseases Unit, IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain
name:University of Vic â Central University of Catalonia (UVic-UCC), Vic, Spain
name:Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
name:Institut dâInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
name:Infectious Diseases Unit, Hospital ClĂnic, Barcelona, Spain
name:Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands
External Links {đ}(112)
- https://www.springernature.com/gp/authors's financial summary
- Learn about the earnings of https://link.springernature.com/home/
- What's the financial outcome of https://order.springer.com/public/cart?
- What's the financial intake of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research?
- How much does https://trialsjournal.biomedcentral.com/about pull in?
- How much income is https://www.editorialmanager.com/trls/ earning monthly?
- How much does https://orcid.org/0000-0001-9674-2647 pull in?
- What's the monthly income of https://www.clinicaltrialsregister.eu/ctr-search/search?query=2016-002724-83?
- Get to know https://clinicaltrials.gov/ct2/show/NCT02888756's earnings
- What are the earnings of http://www.who.int/hiv/data/en/?
- https://doi.org/10.1097%2F00002030-199607000-00009 income
- How much income is http://scholar.google.com/scholar_lookup?&title=HIV-1%20RNA%20levels%20and%20the%20development%20of%20clinical%20disease.%20North%20American%20Lamivudine%20HIV%20Working%20Group&journal=AIDS&doi=10.1097%2F00002030-199607000-00009&volume=10&issue=8&pages=859-865&publication_year=1996&author=Phillips%2CAN&author=Eron%2CJJ&author=Bartlett%2CJA&author=Rubin%2CM&author=Johnson%2CJ&author=Price%2CS earning monthly?
- https://doi.org/10.1038%2Fnm880's revenue stream
- How much does http://scholar.google.com/scholar_lookup?&title=Long-term%20follow-up%20studies%20confirm%20the%20stability%20of%20the%20latent%20reservoir%20for%20HIV-1%20in%20resting%20CD4%2B%20T%20cells&journal=Nat%20Med&doi=10.1038%2Fnm880&volume=9&issue=6&pages=727-728&publication_year=2003&author=Siliciano%2CJD&author=Kajdas%2CJ&author=Finzi%2CD&author=Quinn%2CTC&author=Chadwick%2CK&author=Margolick%2CJB make?
- Learn how profitable https://www.who.int/hiv/pub/progressreports/2016-progress-report/en/ is on a monthly basis
- What's the monthly money flow for https://doi.org/10.1080%2F14760584.2017.1322513?
- Income figures for http://scholar.google.com/scholar_lookup?&title=New%20challenges%20in%20therapeutic%20vaccines%20against%20HIV%20infection&journal=Expert%20Rev%20Vaccines&doi=10.1080%2F14760584.2017.1322513&volume=16&issue=6&pages=587-600&publication_year=2017&author=Leal%2CL&author=Lucero%2CC&author=Gatell%2CJM&author=Gallart%2CT&author=Plana%2CM&author=Garcia%2CF
- Profit of https://doi.org/10.1126%2Fscience.1255512
- Profit of http://scholar.google.com/scholar_lookup?&title=Immunologic%20strategies%20for%20HIV-1%20remission%20and%20eradication&journal=Science&doi=10.1126%2Fscience.1255512&volume=345&issue=6193&pages=169-174&publication_year=2014&author=Barouch%2CDH&author=Deeks%2CSG
- How much money does https://doi.org/10.1111%2Fimr.12083 generate?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Immune%20interventions%20in%20HIV%20infection&journal=Immunol%20Rev&doi=10.1111%2Fimr.12083&volume=254&issue=1&pages=355-371&publication_year=2013&author=Carcelain%2CG&author=Autran%2CB?
- https://doi.org/10.1126%2Fscitranslmed.3004682's total income per month
- How much does http://scholar.google.com/scholar_lookup?&title=A%20dendritic%20cell-based%20vaccine%20elicits%20T%20cell%20responses%20associated%20with%20control%20of%20HIV-1%20replication&journal=Sci%20Transl%20Med&doi=10.1126%2Fscitranslmed.3004682&volume=5&issue=166&publication_year=2013&author=Garcia%2CF&author=Climent%2CN&author=Guardo%2CAC&author=Gil%2CC&author=Leon%2CA&author=Autran%2CB net monthly?
- What's http://scholar.google.com/scholar_lookup?&title=A%20human%20immune%20data-informed%20vaccine%20concept%20elicits%20strong%20and%20broad%20T-cell%20specificities%20associated%20with%20HIV-1%20control%20in%20mice%20and%20macaques&journal=J%20Transl%20Med&doi=10.1186%2Fs12967-015-0392-5&volume=13&publication_year=2015&author=Mothe%2CB&author=Hu%2CX&author=Llano%2CA&author=Rosati%2CM&author=Olvera%2CA&author=Kulkarni%2CV's gross income?
- Learn how profitable https://doi.org/10.1038%2Fmt.2008.77 is on a monthly basis
- http://scholar.google.com/scholar_lookup?&title=Enhancing%20the%20T-cell%20stimulatory%20capacity%20of%20human%20dendritic%20cells%20by%20co-electroporation%20with%20CD40L%2C%20CD70%20and%20constitutively%20active%20TLR4%20encoding%20mRNA&journal=Mol%20Ther&doi=10.1038%2Fmt.2008.77&volume=16&issue=6&pages=1170-1180&publication_year=2008&author=Bonehill%2CA&author=Tuyaerts%2CS&author=Nuffel%2CAM&author=Heirman%2CC&author=Bos%2CTJ&author=Fostier%2CK's financial summary
- Financial intake of https://aidsetc.org/guide/hiv-classification-cdc-and-who-staging-systems
- How much money does https://doi.org/10.1136%2Fbmj.e7586 generate?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=SPIRIT%202013%20explanation%20and%20elaboration%3A%20guidance%20for%20protocols%20of%20clinical%20trials&journal=BMJ&doi=10.1136%2Fbmj.e7586&volume=346&publication_year=2013&author=Chan%2CAW&author=Tetzlaff%2CJM&author=Gotzsche%2CPC&author=Altman%2CDG&author=Mann%2CH&author=Berlin%2CJA?
- Learn how profitable https://doi.org/10.1097%2FQAD.0000000000000987 is on a monthly basis
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Treatment%20interruption%20in%20chronically%20HIV-infected%20patients%20with%20an%20ultralow%20HIV%20reservoir&journal=AIDS&doi=10.1097%2FQAD.0000000000000987&volume=30&issue=5&pages=761-769&publication_year=2016&author=Calin%2CR&author=Hamimi%2CC&author=Lambert-Niclot%2CS&author=Carcelain%2CG&author=Bellet%2CJ&author=Assoumou%2CL
- Explore the financials of https://doi.org/10.1126%2Fscience.1165706
- Income figures for http://scholar.google.com/scholar_lookup?&title=The%20challenge%20of%20finding%20a%20cure%20for%20HIV%20infection&journal=Science&doi=10.1126%2Fscience.1165706&volume=323&issue=5919&pages=1304-1307&publication_year=2009&author=Richman%2CDD&author=Margolis%2CDM&author=Delaney%2CM&author=Greene%2CWC&author=Hazuda%2CD&author=Pomerantz%2CRJ
- How much does https://doi.org/10.1371%2Fjournal.pone.0029717 gross monthly?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=CTL%20responses%20of%20high%20functional%20avidity%20and%20broad%20variant%20cross-reactivity%20are%20associated%20with%20HIV%20control&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0029717&volume=7&issue=1&publication_year=2012&author=Mothe%2CB&author=Llano%2CA&author=Ibarrondo%2CJ&author=Zamarreno%2CJ&author=Schiaulini%2CM&author=Miranda%2CC?
- Financial intake of https://doi.org/10.1158%2F2326-6066.CIR-15-0163
- Get to know http://scholar.google.com/scholar_lookup?&title=Intratumoral%20delivery%20of%20TriMix%20mRNA%20results%20in%20T-cell%20activation%20by%20cross-presenting%20dendritic%20cells&journal=Cancer%20Immunol%20Res&doi=10.1158%2F2326-6066.CIR-15-0163&volume=4&issue=2&pages=146-156&publication_year=2016&author=Lint%2CS&author=Renmans%2CD&author=Broos%2CK&author=Goethals%2CL&author=Maenhout%2CS&author=Benteyn%2CD's earnings
- Earnings of http://scholar.google.com/scholar_lookup?&title=Optimized%20dendritic%20cell-based%20immunotherapy%20for%20melanoma%3A%20the%20TriMix-formula&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-014-1558-3&volume=63&issue=9&pages=959-967&publication_year=2014&author=Lint%2CS&author=Wilgenhof%2CS&author=Heirman%2CC&author=Corthals%2CJ&author=Breckpot%2CK&author=Bonehill%2CA
- https://doi.org/10.1038%2Fnature20583 income
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Ad26%2FMVA%20therapeutic%20vaccination%20with%20TLR7%20stimulation%20in%20SIV-infected%20rhesus%20monkeys&journal=Nature&doi=10.1038%2Fnature20583&volume=540&issue=7632&pages=284-287&publication_year=2016&author=Borducchi%2CEN&author=Cabral%2CC&author=Stephenson%2CKE&author=Liu%2CJ&author=Abbink%2CP&author=Ng%27ang%27a%2CD?
- Monthly income for https://doi.org/10.1016%2Fj.clim.2011.10.010
- Financial intake of http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%2FIIa%20immunotherapy%20trial%20of%20HIV-1-infected%20patients%20with%20Tat%2C%20Rev%20and%20Nef%20expressing%20dendritic%20cells%20followed%20by%20treatment%20interruption&journal=Clin%20Immunol&doi=10.1016%2Fj.clim.2011.10.010&volume=142&issue=3&pages=252-268&publication_year=2012&author=Allard%2CSD&author=Keersmaecker%2CB&author=Goede%2CAL&author=Verschuren%2CEJ&author=Koetsveld%2CJ&author=Reedijk%2CML
- Revenue of https://doi.org/10.1021%2Facs.nanolett.5b02497
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Optimization%20of%20lipid%20nanoparticle%20formulations%20for%20mRNA%20delivery%20in%20vivo%20with%20fractional%20factorial%20and%20definitive%20screening%20designs&journal=Nano%20Lett&doi=10.1021%2Facs.nanolett.5b02497&volume=15&issue=11&pages=7300-7306&publication_year=2015&author=Kauffman%2CKJ&author=Dorkin%2CJR&author=Yang%2CJH&author=Heartlein%2CMW&author=DeRosa%2CF&author=Mir%2CFF?
- Check the income stats for https://doi.org/10.1021%2Facs.nanolett.6b03329
- What's http://scholar.google.com/scholar_lookup?&title=Lipid%20nanoparticle%20assisted%20mRNA%20delivery%20for%20potent%20cancer%20immunotherapy&journal=Nano%20Lett&doi=10.1021%2Facs.nanolett.6b03329&volume=17&issue=3&pages=1326-1335&publication_year=2017&author=Oberli%2CMA&author=Reichmuth%2CAM&author=Dorkin%2CJR&author=Mitchell%2CMJ&author=Fenton%2COS&author=Jaklenec%2CA's gross income?
- How much profit is https://doi.org/10.1016%2Fj.jconrel.2010.10.020 making per month?
- http://scholar.google.com/scholar_lookup?&title=mRNA%20as%20gene%20therapeutic%3A%20how%20to%20control%20protein%20expression&journal=J%20Control%20Release&doi=10.1016%2Fj.jconrel.2010.10.020&volume=150&issue=3&pages=238-247&publication_year=2011&author=Tavernier%2CG&author=Andries%2CO&author=Demeester%2CJ&author=Sanders%2CNN&author=Smedt%2CSC&author=Rejman%2CJ's revenue stream
- How much cash flow does https://doi.org/10.4161%2Fhv.22661 have monthly?
- Income figures for http://scholar.google.com/scholar_lookup?&title=mRNA%3A%20from%20a%20chemical%20blueprint%20for%20protein%20production%20to%20an%20off-the-shelf%20therapeutic&journal=Hum%20Vaccin%20Immunother&doi=10.4161%2Fhv.22661&volume=9&issue=2&pages=265-274&publication_year=2013&author=Lint%2CS&author=Heirman%2CC&author=Thielemans%2CK&author=Breckpot%2CK
- Find out how much https://doi.org/10.1093%2Finfdis%2Fjiu534 earns monthly
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Alternative%20effector-function%20profiling%20identifies%20broad%20HIV-specific%20T-cell%20responses%20in%20highly%20HIV-exposed%20individuals%20who%20remain%20uninfected&journal=J%20Infect%20Dis&doi=10.1093%2Finfdis%2Fjiu534&volume=211&issue=6&pages=936-946&publication_year=2015&author=Ruiz-Riol%2CM&author=Llano%2CA&author=Ibarrondo%2CJ&author=Zamarreno%2CJ&author=Yusim%2CK&author=Bach%2CV?
- What's the total monthly financial gain of https://doi.org/10.1016%2Fj.jim.2017.03.014?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Human%20immune%20compartment%20comparisons%3A%20optimization%20of%20proliferative%20assays%20for%20blood%20and%20gut%20T%20lymphocytes&journal=J%20Immunol%20Methods&doi=10.1016%2Fj.jim.2017.03.014&volume=445&pages=77-87&publication_year=2017&author=Dock%2CJ&author=Hultin%2CL&author=Hultin%2CP&author=Elliot%2CJ&author=Yang%2COO&author=Anton%2CPA?
- What is the monthly revenue of https://doi.org/10.1371%2Fjournal.pone.0074855?
- How much money does http://scholar.google.com/scholar_lookup?&title=High%20antibody-dependent%20cellular%20cytotoxicity%20responses%20are%20correlated%20with%20strong%20CD8%20T%20cell%20viral%20suppressive%20activity%20but%20not%20with%20B57%20status%20in%20HIV-1%20elite%20controllers&journal=PLoS%20One&doi=10.1371%2Fjournal.pone.0074855&volume=8&issue=9&publication_year=2013&author=Lambotte%2CO&author=Pollara%2CJ&author=Boufassa%2CF&author=Moog%2CC&author=Venet%2CA&author=Haynes%2CBF generate?
- Financial intake of https://doi.org/10.1097%2FQAD.0b013e32834f33e8
- How much income does http://scholar.google.com/scholar_lookup?&title=mRNA-based%20dendritic%20cell%20vaccination%20induces%20potent%20antiviral%20T-cell%20responses%20in%20HIV-1-infected%20patients&journal=AIDS&doi=10.1097%2FQAD.0b013e32834f33e8&volume=26&issue=4&pages=F1-12&publication_year=2012&author=Gulck%2CE&author=Vlieghe%2CE&author=Vekemans%2CM&author=Tendeloo%2CVF&author=Velde%2CA&author=Smits%2CE have?
- Get to know https://doi.org/10.1016%2Fj.vaccine.2015.04.047's earnings
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=DC%20immunotherapy%20in%20HIV-1%20infection%20induces%20a%20major%20blood%20transcriptome%20shift&journal=Vaccine&doi=10.1016%2Fj.vaccine.2015.04.047&volume=33&issue=25&pages=2922-2929&publication_year=2015&author=Goede%2CAL&author=Andeweg%2CAC&author=Ham%2CHJ&author=Bijl%2CMA&author=Zaaraoui-Boutahar%2CF&author=IJcken%2CWF each month?
- Learn about the earnings of https://doi.org/10.1097%2F01.aids.0000433813.67662.92
- http://scholar.google.com/scholar_lookup?&title=HIV-1%20evolution%20in%20patients%20undergoing%20immunotherapy%20with%20Tat%2C%20Rev%2C%20and%20Nef%20expressing%20dendritic%20cells%20followed%20by%20treatment%20interruption&journal=AIDS&doi=10.1097%2F01.aids.0000433813.67662.92&volume=27&issue=17&pages=2679-2689&publication_year=2013&author=Goede%2CAL&author=Deutekom%2CHW&author=Vrancken%2CB&author=Schutten%2CM&author=Allard%2CSD&author=Baalen%2CCA's total income per month
- How much revenue does https://citation-needed.springer.com/v2/references/10.1186/s13063-019-3409-1?format=refman&flavour=references bring in?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wesley%20de%20Jong?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wesley%20de%20Jong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Joeri%20Aerts each month?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Joeri%20Aerts%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sabine%20Allard's earnings
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sabine%20Allard%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Get to know https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Christian%20Brander's earnings
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Christian%20Brander%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jozefien%20Buyze
- Check the income stats for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jozefien%20Buyze%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Eric%20Florence's revenue stream
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Eric%20Florence%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Eric%20van%20Gorp net monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Eric%20van%20Gorp%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Guido%20Vanham
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Guido%20Vanham%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lorna%20Leal
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lorna%20Leal%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Beatriz%20Mothe?
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Beatriz%20Mothe%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kris%20Thielemans pull in?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kris%20Thielemans%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Montse%20Plana bring in each month?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Montse%20Plana%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=F%C3%A9lipe%20Garcia's revenue stream
- See how much https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22F%C3%A9lipe%20Garcia%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en makes per month
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rob%20Gruters
- What's the monthly money flow for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rob%20Gruters%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What is the monthly revenue of https://static-content.springer.com/esm/art%3A10.1186%2Fs13063-019-3409-1/MediaObjects/13063_2019_3409_MOESM1_ESM.doc?
- How much revenue does http://creativecommons.org/licenses/by/4.0/ bring in?
- How much income is http://creativecommons.org/publicdomain/zero/1.0/ earning monthly?
- How much does https://s100.copyright.com/AppDispatchServlet?title=iHIVARNA%20phase%20IIa%2C%20a%20randomized%2C%20placebo-controlled%2C%20double-blinded%20trial%20to%20evaluate%20the%20safety%20and%20immunogenicity%20of%20iHIVARNA-01%20in%20chronically%20HIV-infected%20patients%20under%20stable%20combined%20antiretroviral%20therapy&author=Wesley%20de%20Jong%20F.%20G.%20et%20al&contentID=10.1186%2Fs13063-019-3409-1©right=The%20Author%28s%29.&publication=1745-6215&publicationDate=2019-06-17&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0 rake in every month?
- https://crossmark.crossref.org/dialog/?doi=10.1186/s13063-019-3409-1's total income per month
- What is the monthly revenue of https://citation-needed.springer.com/v2/references/10.1186/s13063-019-3409-1?format=refman&flavour=citation?
- https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's total income per month
- How much profit is https://www.springernature.com/gp/products making per month?
- What are the earnings of https://www.springernature.com/gp/librarians?
- Financial intake of https://www.springernature.com/gp/societies
- Find out how much https://www.springernature.com/gp/partners earns monthly
- https://www.springer.com/ income
- Find out how much https://www.nature.com/ earns monthly
- What's the monthly money flow for https://www.biomedcentral.com/?
- Get to know https://www.palgrave.com/'s earnings
- Explore the financials of https://www.apress.com/
- What's the profit of https://www.springernature.com/gp/legal/ccpa?
- What is the monthly revenue of https://www.springernature.com/gp/info/accessibility?
- Find out how much https://support.springernature.com/en/support/home earns monthly
- https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's total income per month
- What's the monthly income of https://www.springernature.com/?
Analytics and Tracking {đ}
- Google Tag Manager
Libraries {đ}
- Clipboard.js
- Particles.js
- Prism.js
CDN Services {đŚ}
- Crossref